Latest News

Abbott Laboratories says FDA independent panel votes to approve heart device


Abbott Laboratories ABT said that a Food and Drug Administration panel voted in favor of the safety profile of its heart device TriClip.

The medical device company on Tuesday said that the Circulatory System Devices Panel of the Medical Devices Advisory Committee also confirmed the effectiveness and risk/benefit profile of the device to treat people with tricuspid regurgitation.


How To Invest In Real Estate Online: Crowdfunding And REITs

Previous article

Airbnb’s stock falls despite revenue beat, positive guidance

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News